| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 8,844,536 | 11,109,092 | 7,945,698 | | Cost of Revenue | 3,081,915 | 3,701,108 | 2,888,236 | | | Gross Profit | 5,762,621 | 7,407,984 | 5,057,462 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,559,139 | 2,615,597 | 2,301,971 | | Non Recurring | (138,476) | 119,017 | (141,280) | | Others |
-
| 1,438,434 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,341,958 | 3,234,936 | 2,896,770 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 15,159 | 1,008,617 | (523,152) | | Earnings Before Interest And Taxes | 3,358,056 | 4,243,553 | 2,373,619 | | Interest Expense | 523,630 | 546,403 |
-
| | Income Before Tax | 2,834,426 | 3,697,151 | 2,373,619 | | Income Tax Expense | 617,954 | 892,032 | 491,267 | | Minority Interest |
-
| (28,327) | 1,266 | | | | Net Income From Continuing Ops | 2,216,514 | 2,776,792 | 1,920,943 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 2,216,514 | 2,776,792 | 1,920,943 | | Preferred Stock And Other Adjustments | (30,659) |
-
|
-
| | | Net Income Applicable To Common Shares | $2,185,856 | $2,776,792 | $1,920,943 |
|
0.24% Nasdaq 
0.31%
Income Statement
